Beyond Tick Maps: Is the Healthcare System Prepared for Alpha-gal Syndrome?

"Our goal is clear: reduce Lyme disease cases by 25% by 2035."

The U.S. Department of Health's new initiative reflects growing recognition of the public health impact of tick-borne diseases. Prevention efforts are essential.

Yet for many patients already living with Alpha-gal Syndrome (AGS), another question remains:

As the nation works to prevent future cases, is the healthcare system prepared to recognize, diagnose, and manage the full spectrum of tick-associated conditions today?

A Broader Geographic Footprint Than Many Realize

Much of the public conversation surrounding Alpha-gal Syndrome focuses on the Lone Star tick and the southeastern United States. Recent media coverage has increasingly highlighted concerns about ticks expanding into new geographic regions.

However, patient-reported data suggest the conversation may already be broader than many people realize.

TickBiteData has received survey responses from individuals who report being bitten by a tick and later receiving an Alpha-gal Syndrome diagnosis in states far beyond the regions most commonly associated with the condition. These reports include western states such as California and Oregon, where participants describe tick exposure followed by a subsequent Alpha-gal diagnosis. 

Research has also identified alpha-gal sensitization associated with multiple tick species in different regions of the world, suggesting that the story may be more complex than a single tick species or a single geographic region.

The conversation is no longer simply about where ticks may be moving.

It is also about where patients are already reporting illness.

The Awareness Gap

One of the most consistent themes emerging from patient-reported data is not geography—it is diagnosis.

Nearly two-thirds of survey participants report being initially misdiagnosed before receiving an Alpha-gal Syndrome diagnosis. Many describe years of unexplained symptoms, repeated healthcare visits, specialist referrals, and emergency department encounters before the condition was identified.

Others report encountering healthcare providers with limited familiarity with the condition or uncertainty about how to test for and manage it.

These experiences raise an important public health question:

As attention turns toward reducing tick-borne disease nationwide, what strategies are being implemented to ensure healthcare providers, hospitals, emergency departments, and specialists are prepared to recognize and manage the full spectrum of tick-associated conditions, including Alpha-gal Syndrome?

Prevention and Preparedness Must Work Together

For many patients, diagnosis is only the beginning.

Survey participants frequently describe challenges related to food and medication exposures, cross-contamination, healthcare encounters, repeat tick bites, and the long-term impact of the condition on daily life. These experiences suggest that clinical preparedness requires more than awareness alone—it requires providers to understand the broader clinical picture patients may face after diagnosis.

As public health agencies invest in prevention, surveillance, and tick-borne disease awareness, there is also an opportunity to strengthen healthcare system readiness through clinician education, diagnostic awareness, and evidence-based care pathways.

Understanding where ticks are found remains essential.

Understanding how to care for the people affected by tick-associated conditions is equally important.

Looking Beyond Tick Maps

Tick distribution maps help us understand where risk may exist.

Patient-reported data help us understand where people are already living with the consequences.

As public health efforts evolve, there is an opportunity to move beyond vector surveillance alone and consider healthcare preparedness, diagnostic awareness, and the long-term burden on patients and families.

The goal of reducing tick-borne disease is one worth celebrating.

But prevention is only part of the equation.

The question is not simply where ticks may be moving next.

The question is whether the healthcare system is prepared when patients arrive seeking answers.

TickBiteData collects anonymous patient-reported information to better understand the experiences of individuals affected by Alpha-gal Syndrome and other tick-associated conditions. Survey findings reflect self-reported experiences and should not be interpreted as prevalence estimates or clinical conclusions. Rather, they provide insight into emerging patterns, diagnostic experiences, and the broader public health impact on patients and families.